Edition:
United Kingdom

Alliqua BioMedical Inc (ALQA.OQ)

ALQA.OQ on NASDAQ Stock Exchange Capital Market

2.01USD
19 Oct 2018
Change (% chg)

$-0.05 (-2.67%)
Prev Close
$2.06
Open
$2.07
Day's High
$2.12
Day's Low
$2.00
Volume
610
Avg. Vol
3,914
52-wk High
$3.81
52-wk Low
$1.59

Latest Key Developments (Source: Significant Developments)

Alliqua Biomedical Terminates Credit Agreement & Guaranty Dated May 29, 2015
Monday, 7 May 2018 

May 7 (Reuters) - Alliqua BioMedical Inc ::ALLIQUA BIOMEDICAL SAYS ON MAY 7,IN RELATION TO COMPLETION OF ASSET SALE, CO TERMINATED CREDIT AGREEMENT & GUARANTY DATED MAY 29, 2015 - SEC FILING.ALLIQUA BIOMEDICAL INC - CO ALSO TERMINATED RELATED PLEDGE AND SECURITY AGREEMENT, DATED AS OF MAY 29, 2015.  Full Article

Alliqua Biomedical Says Has Right To Terminate Agreement With Celularity, Provided Co Pays $1.45 Mln Fee
Friday, 5 Jan 2018 

Jan 5 (Reuters) - Alliqua Biomedical Inc ::ALLIQUA BIOMEDICAL SAYS HAS RIGHT TO TERMINATE ASSET PURCHASE AGREEMENT WITH CELULARITY, PROVIDED CO PAYS TERMINATION FEE OF $1.45 MILLION - SEC FILING.ALLIQUA BIOMEDICAL INC - CELULARITY MAY BE OBLIGATED TO PAY A $3 MILLION REVERSE TERMINATION FEE IF ASSET PURCHASE AGREEMENT IS TERMINATED BY CO.  Full Article

Alliqua Biomedical Announces Definitive Asset Purchase Agreement With Celularity Inc
Friday, 5 Jan 2018 

Jan 5 (Reuters) - Alliqua Biomedical Inc ::ALLIQUA BIOMEDICAL, INC. ANNOUNCES DEFINITIVE ASSET PURCHASE AGREEMENT WITH CELULARITY, INC..ALLIQUA BIOMEDICAL INC - DEAL FOR $29.0 MILLION.ALLIQUA BIOMEDICAL - AS PER DEAL, CELULARITY WILL ACQUIRE ALL OF PROPERTY, ASSETS AND RIGHTS RELATING TO CO'S ADVANCED BIOLOGIC WOUND CARE BUSINESS.ALLIQUA BIOMEDICAL - AS PER DEAL, CELULARITY WILL ALSO ACQUIRE ALL OF PROPERTY, ASSETS AND RIGHTS RELATING TO CO'S ULTRAMIST THERAPY SYSTEM.ALLIQUA BIOMEDICAL INC - CO'S BOARD OF DIRECTORS UNANIMOUSLY APPROVED ENTERING INTO AGREEMENT.ALLIQUA BIOMEDICAL INC - NO DEBT OR SIGNIFICANT LIABILITIES ARE BEING ASSUMED BY CELULARITY IN TRANSACTION.  Full Article

Alliqua BioMedical engages Cowen to assist in evaluating potential strategic alternatives
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Alliqua BioMedical Inc :Alliqua BioMedical Inc engages Cowen to assist in evaluating potential strategic alternatives.Alliqua BioMedical Inc - engaged Cowen as its independent financial advisor to assist co in evaluating potential strategic alternatives​.  Full Article

Alliqua Biomedical says co and Celgene entered into side letter agreement
Wednesday, 15 Mar 2017 

Alliqua Biomedical Inc : On March 13, 2017, co and Celgene entered into a side letter agreement - sec filing . co, chairman Jerome Zeldis entered into side letter agreement; Zeldis to conditionally waive MFN adjustment in securities purchase deal . Celgene agreed to waive MFN adjustment in spa to extent MFN adjustment would cause Celgene to own in excess of 19.9% of co's common stock Further company coverage: [ALQA.O] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Alliqua Biomedical reports Q3 GAAP loss per share $0.30
Friday, 4 Nov 2016 

Alliqua Biomedical Inc : Reports third quarter and nine-months fiscal year 2016 financial results . Q3 non-GAAP loss per share $0.16 from continuing operations . Q3 GAAP loss per share $0.30 . Q3 revenue $4.9 million versus I/B/E/S view $4.8 million . Sees FY 2016 revenue $18.3 million to $19 million . Q3 earnings per share view $-0.24 -- Thomson Reuters I/B/E/S .FY2016 earnings per share view $-0.74, revenue view $18.7 million -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Alliqua Biomedical Terminates Credit Agreement & Guaranty Dated May 29, 2015

* ALLIQUA BIOMEDICAL SAYS ON MAY 7,IN RELATION TO COMPLETION OF ASSET SALE, CO TERMINATED CREDIT AGREEMENT & GUARANTY DATED MAY 29, 2015 - SEC FILING